NUTRIBAND INC. (NTRB) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Win.
32/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseNTRB / S&P -9.63% / 15.20% |
LoseNTRB / S&P -24.84% / 15.00% |
WinNTRB / S&P 186.67% / 50.40% |
| 2026-Q11/3 |
LoseNTRB / S&P -22.25% / -4.33% |
LoseNTRB / S&P -4.81% / 11.30% |
WinNTRB / S&P 162.63% / 27.70% |
| 2025-Q42/3 |
LoseNTRB / S&P -35.60% / 2.65% |
WinNTRB / S&P 12.69% / 9.00% |
WinNTRB / S&P 332.39% / 13.40% |
| 2025-Q32/3 |
LoseNTRB / S&P -10.42% / 8.12% |
WinNTRB / S&P 42.92% / 4.61% |
WinNTRB / S&P 254.32% / 13.45% |
| 2025-Q23/3 |
WinNTRB / S&P 28.38% / 10.94% |
WinNTRB / S&P 18.92% / 4.83% |
WinNTRB / S&P 16.88% / 10.63% |
| 2025-Q12/3 |
WinNTRB / S&P 30.15% / -4.27% |
LoseNTRB / S&P 2.60% / 4.98% |
WinNTRB / S&P 43.48% / 10.57% |
| 2024-Q40/3 |
LoseNTRB / S&P -22.15% / 2.41% |
LoseNTRB / S&P -3.19% / 5.25% |
LoseNTRB / S&P 5.97% / 6.15% |
| 2024-Q32/3 |
WinNTRB / S&P 12.04% / 5.89% |
LoseNTRB / S&P -20.83% / 5.89% |
WinNTRB / S&P 37.29% / 6.11% |
| 2024-Q22/3 |
WinNTRB / S&P 19.47% / 4.28% |
LoseNTRB / S&P -2.97% / 5.38% |
WinNTRB / S&P 28.33% / 5.12% |
| 2024-Q12/3 |
WinNTRB / S&P 94.83% / 10.56% |
LoseNTRB / S&P 0.27% / 5.71% |
WinNTRB / S&P 25.45% / 5.59% |
| 2023-Q41/3 |
LoseNTRB / S&P -9.02% / 11.69% |
WinNTRB / S&P 15.93% / 6.81% |
LoseNTRB / S&P -16.25% / 7.78% |
| 2023-Q31/3 |
LoseNTRB / S&P -15.00% / -3.27% |
WinNTRB / S&P 55.37% / 7.52% |
LoseNTRB / S&P -33.71% / -5.03% |
| 2023-Q21/3 |
LoseNTRB / S&P -9.37% / 8.74% |
WinNTRB / S&P 69.82% / 9.50% |
LoseNTRB / S&P -28.57% / -8.57% |
| 2023-Q11/3 |
LoseNTRB / S&P -8.18% / 7.50% |
WinNTRB / S&P 76.30% / 10.77% |
LoseNTRB / S&P NTRB unavailable / -15.69% |
| 2022-Q41/3 |
LoseNTRB / S&P 0.42% / 7.56% |
WinNTRB / S&P 68.02% / 11.88% |
LoseNTRB / S&P NTRB unavailable / -17.99% |
| 2022-Q32/3 |
WinNTRB / S&P 1.85% / -4.88% |
WinNTRB / S&P 24.18% / 13.47% |
LoseNTRB / S&P NTRB unavailable / -1.41% |
| 2022-Q22/3 |
WinNTRB / S&P -2.38% / -16.10% |
WinNTRB / S&P 16.39% / 13.71% |
LoseNTRB / S&P NTRB unavailable / 11.04% |
| 2022-Q11/3 |
LoseNTRB / S&P -58.23% / -4.60% |
WinNTRB / S&P 59.94% / 15.97% |
LoseNTRB / S&P NTRB unavailable / 42.23% |
| 2021-Q41/3 |
LoseNTRB / S&P NTRB unavailable / 11.03% |
WinNTRB / S&P 74.28% / 15.00% |
LoseNTRB / S&P NTRB unavailable / 96.40% |
| 2021-Q31/3 |
LoseNTRB / S&P NTRB unavailable / 0.58% |
WinNTRB / S&P 285.98% / 10.77% |
LoseNTRB / S&P NTRB unavailable / 69.42% |
| 2021-Q21/3 |
LoseNTRB / S&P NTRB unavailable / 8.55% |
WinNTRB / S&P 254.78% / 6.58% |
LoseNTRB / S&P NTRB unavailable / 51.81% |
| 2021-Q11/3 |
LoseNTRB / S&P NTRB unavailable / 6.17% |
WinNTRB / S&P 98.98% / -1.06% |
LoseNTRB / S&P NTRB unavailable / 7.39% |
| 2020-Q41/3 |
LoseNTRB / S&P NTRB unavailable / 12.15% |
WinNTRB / S&P 41.90% / -3.72% |
LoseNTRB / S&P NTRB unavailable / -33.42% |
| 2020-Q30/3 |
LoseNTRB / S&P NTRB unavailable / 8.93% |
LoseNTRB / S&P -40.45% / -2.04% |
LoseNTRB / S&P NTRB unavailable / -27.10% |
| 2020-Q20/3 |
LoseNTRB / S&P NTRB unavailable / 20.54% |
LoseNTRB / S&P NTRB unavailable / -0.46% |
LoseNTRB / S&P NTRB unavailable / -27.11% |
| 2020-Q10/3 |
LoseNTRB / S&P NTRB unavailable / -19.60% |
LoseNTRB / S&P NTRB unavailable / 3.47% |
LoseNTRB / S&P NTRB unavailable / -14.75% |
| 2019-Q40/3 |
LoseNTRB / S&P NTRB unavailable / 9.07% |
LoseNTRB / S&P NTRB unavailable / 5.36% |
LoseNTRB / S&P NTRB unavailable / 2.99% |
| 2019-Q30/3 |
LoseNTRB / S&P NTRB unavailable / 1.70% |
LoseNTRB / S&P NTRB unavailable / 5.02% |
LoseNTRB / S&P NTRB unavailable / 0.21% |
| 2019-Q20/3 |
LoseNTRB / S&P NTRB unavailable / 4.30% |
LoseNTRB / S&P NTRB unavailable / 6.64% |
LoseNTRB / S&P NTRB unavailable / 8.65% |
| 2019-Q10/3 |
LoseNTRB / S&P NTRB unavailable / 13.65% |
LoseNTRB / S&P NTRB unavailable / 8.12% |
LoseNTRB / S&P NTRB unavailable / 14.29% |
| 2018-Q40/3 |
LoseNTRB / S&P NTRB unavailable / -13.52% |
LoseNTRB / S&P NTRB unavailable / 9.05% |
LoseNTRB / S&P NTRB unavailable / 18.23% |
| 2018-Q30/3 |
LoseNTRB / S&P NTRB unavailable / 7.71% |
LoseNTRB / S&P NTRB unavailable / 10.21% |
LoseNTRB / S&P NTRB unavailable / 19.06% |
| 2018-Q20/3 |
LoseNTRB / S&P NTRB unavailable / 3.43% |
LoseNTRB / S&P NTRB unavailable / 9.03% |
LoseNTRB / S&P NTRB unavailable / 14.46% |
| 2018-Q10/3 |
LoseNTRB / S&P NTRB unavailable / -0.76% |
LoseNTRB / S&P NTRB unavailable / 7.68% |
LoseNTRB / S&P NTRB unavailable / 12.46% |
| 2017-Q40/3 |
LoseNTRB / S&P NTRB unavailable / 6.64% |
LoseNTRB / S&P NTRB unavailable / 7.03% |
LoseNTRB / S&P NTRB unavailable / 13.82% |
| 2017-Q30/3 |
LoseNTRB / S&P NTRB unavailable / 4.48% |
LoseNTRB / S&P NTRB unavailable / 5.68% |
LoseNTRB / S&P NTRB unavailable / 17.57% |
| 2017-Q20/3 |
LoseNTRB / S&P NTRB unavailable / 3.09% |
LoseNTRB / S&P NTRB unavailable / 4.83% |
LoseNTRB / S&P NTRB unavailable / 17.74% |
| 2017-Q10/3 |
LoseNTRB / S&P NTRB unavailable / 6.07% |
LoseNTRB / S&P NTRB unavailable / 3.67% |
LoseNTRB / S&P NTRB unavailable / 13.32% |
| 2016-Q40/3 |
LoseNTRB / S&P NTRB unavailable / 3.82% |
LoseNTRB / S&P NTRB unavailable / 2.09% |
LoseNTRB / S&P NTRB unavailable / 7.05% |
| 2016-Q30/3 |
LoseNTRB / S&P NTRB unavailable / 3.85% |
LoseNTRB / S&P NTRB unavailable / 0.20% |
LoseNTRB / S&P NTRB unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | NTRB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -28.54% | 20.78% |
| Annualized return | -28.54% | 20.78% |
5Y · 2021-10-01 to 2026-08-27
| Metric | NTRB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -19.48% | 83.14% |
| Annualized return | -4.24% | 12.86% |
10Y · 2021-10-01 to 2026-08-27
| Metric | NTRB total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -19.48% | 319.30% |
| Annualized return | -2.14% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |